Showing 1 - 7 results of 7 for search 'The COVID-19 Immunoprofiling Team', query time: 0.04s Refine Results
  1. 1
    Sustained spike-specific IgG antibodies following CoronaVac (Sinovac) vaccination in sub-Saharan Africa, but increased breakthrough infections in baseline spike-naive individuals

    Sustained spike-specific IgG antibodies following CoronaVac (Sinovac) vaccination in sub-Saharan Africa, but increased breakthrough infections in baseline spike-naive individuals by Jackson Sembera, Claire Baine, Violet Ankunda, Joseph Ssebwana Katende, Joseph Ssebwana Katende, Gerald Kevin Oluka, Gerald Kevin Oluka, Christine Hermilia Akoli, Laban Kato, Geoffrey Odoch, Peter Ejou, Solomon Opio, Monica Musenero, The COVID-19 Immunoprofiling Team, The COVID-19 Immunoprofiling Team, Pontiano Kaleebu, Pontiano Kaleebu, Jennifer Serwanga, Jennifer Serwanga

    Published 2023-11-01
    Get full text
    Article
  2. 2
    Sustained S-IgG and S-IgA antibodies to Moderna’s mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations

    Sustained S-IgG and S-IgA antibodies to Moderna’s mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations by Jennifer Serwanga, Jennifer Serwanga, Violet Ankunda, Joseph Ssebwana Katende, Joseph Ssebwana Katende, Claire Baine, Gerald Kevin Oluka, Gerald Kevin Oluka, Geoffrey Odoch, Hellen Nantambi, Susan Mugaba, Angella Namuyanja, Ivan Ssali, Peter Ejou, Laban Kato, The COVID-19 Immunoprofiling Team, The COVID-19 Immunoprofiling Team, Monica Musenero, Pontiano Kaleebu, Pontiano Kaleebu, Jackson Sembera, Betty Oliver Auma, Solomon Opio, Ben Gombe

    Published 2024-01-01
    Get full text
    Article
  3. 3
    The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies

    The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies by Violet Ankunda, Joseph Ssebwana Katende, Joseph Ssebwana Katende, Gerald Kevin Oluka, Gerald Kevin Oluka, Jackson Sembera, Claire Baine, Geoffrey Odoch, Peter Ejou, Laban Kato, The COVID-19 Immunoprofiling Team, The COVID-19 Immunoprofiling Team, Pontiano Kaleebu, Pontiano Kaleebu, Jennifer Serwanga, Jennifer Serwanga, Christine Hermilia Akoli, Angela Namuyanja, Solomon Opio, Arthur Watelo Kalyebi, Ivan Ssali, Ben Gombe, Susan Mugaba, Hellen Nantambi

    Published 2024-02-01
    Get full text
    Article
  4. 4
    Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda

    Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda by Gerald Kevin Oluka, Gerald Kevin Oluka, Patricia Namubiru, Laban Kato, Violet Ankunda, Ben Gombe, Matthew Cotten, Matthew Cotten, The COVID-19 Immunoprofiling Team, The COVID-19 Immunoprofiling Team, Monica Musenero, Pontiano Kaleebu, Pontiano Kaleebu, Julie Fox, Jennifer Serwanga, Jennifer Serwanga, Claire Baine, Jackson Sembera, Susan Mugaba, Christine Hermilia Akoli, Geoffrey Odoch, Deus Mwesigwa, Peter Ejou, Joseph Ssebwana Katende

    Published 2023-03-01
    Get full text
    Article
  5. 5
    Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy

    Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy by Jennifer Serwanga, Jennifer Serwanga, Claire Baine, Susan Mugaba, Violet Ankunda, Betty Oliver Auma, Gerald Kevin Oluka, Gerald Kevin Oluka, Laban Kato, Isaac Kitabye, Jackson Sembera, Geoffrey Odoch, Peter Ejou, Amina Nalumansi, Ben Gombe, Monica Musenero, Pontiano Kaleebu, Pontiano Kaleebu, the COVID-19 Immunoprofiling Team, the COVID-19 Immunoprofiling Team, Christine Hermilia Akoli, Deus Mwesigwa, Ivan Ssali, Hellen Nantambi, Angela Namuyanja, Solomon Opio, Arthur Watelo Kalyebi, Joseph Ssebwana Katende

    Published 2023-05-01
    Get full text
    Article
  6. 6
    Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens

    Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens by Hellen Nantambi, Hellen Nantambi, Hellen Nantambi, Jackson Sembera, Jackson Sembera, Violet Ankunda, Ivan Ssali, Arthur Watelo Kalyebi, Arthur Watelo Kalyebi, Gerald Kevin Oluka, Gerald Kevin Oluka, Laban Kato, Bahemuka Ubaldo, Freddie Kibengo, Joseph Ssebwana Katende, Joseph Ssebwana Katende, Ben Gombe, Claire Baine, Geoffrey Odoch, Susan Mugaba, Obondo James Sande, The COVID-19 Immunoprofiling Team, The COVID-19 Immunoprofiling Team, Pontiano Kaleebu, Pontiano Kaleebu, Jennifer Serwanga, Jennifer Serwanga

    Published 2023-04-01
    Get full text
    Article
  7. 7
    Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months

    Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months by Jennifer Serwanga, Jennifer Serwanga, Violet Ankunda, Jackson Sembera, Laban Kato, Gerald Kevin Oluka, Gerald Kevin Oluka, Claire Baine, Geoffrey Odoch, John Kayiwa, Betty Oliver Auma, Mark Jjuuko, Christopher Nsereko, Matthew Cotten, Matthew Cotten, Nathan Onyachi, Moses Muwanga, Tom Lutalo, Julie Fox, Monica Musenero, Pontiano Kaleebu, Pontiano Kaleebu, The COVID-19 Immunoprofiling Team, The COVID-19 Immunoprofiling Team, Patricia Namubiru, Hermilia Christine Akoli, Susan Mugaba, Amina Nalumansi, Geoffrey Odoch, Kibengo Freddie, Deus Mwesigwa, Joseph Ssebwana Katende

    Published 2023-03-01
    Get full text
    Article

Search Tools: